A Survival Prediction for Acute Heart Failure Patients via Web-Based Dynamic Nomogram with Internal Validation: A Prospective Cohort Study

References

• Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi:10.15420/cfr.2016:25:2
   PubMedGoogle Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail Aug. 2017;23(8):628–651.
   PubMed Web of Science ®Google Scholar
• Khera R, Dharmarajan K, Krumholz HM. Rising mortality in patients with heart failure in the United States: facts versus fiction. JACC Heart Fail. 2018;6:610–612. doi:10.1016/j.jchf.2018.02.011
   PubMed Web of Science ®Google Scholar
• Wessler BS, Ruthazer R, Udelson JE, et al. Regional validation and recalibration of clinical predictive models for patients with acute heart failure. J Am Heart Assoc. 2017;6:e006121. doi:10.1161/JAHA.117.006121
   PubMed Web of Science ®Google Scholar
• Rahimi K, Bennett D, Conrad N, et al. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014;2:440–446. doi:10.1016/j.jchf.2014.04.008
   PubMed Web of Science ®Google Scholar
• Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–1433. doi:10.1161/CIRCULATIONAHA.105.584102
   PubMed Web of Science ®Google Scholar
• Pocock SJ, Ariti CA, McMurray JJ, et al. Predicting survival in heart failure: a risk score based on 39372 patients from 30 studies. Eur Heart J. 2013;34:1404–1413. doi:10.1093/eurheartj/ehs337
   PubMed Web of Science ®Google Scholar
• Sartipy U, Dahlstrom U, Edner M, et al. Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry. Eur J Heart Fail. 2014;16:173–179. doi:10.1111/ejhf.32
   PubMed Web of Science ®Google Scholar
• Sato N, Kajimoto K, Keida T, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND registry). Circ J. 2013;77:944–951. doi:10.1253/circj.CJ-13-0187
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Kohsaka S, Nagai T, et al. Validation and recalibration of Seattle Heart Failure Model in Japanese acute heart failure patients. J Card Fail Jul. 2019;25(7):561–567. doi:10.1016/j.cardfail.2018.07.463
   PubMed Web of Science ®Google Scholar
• Voors AA, Ouwerkerk W, Zannad F, et al. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail. 2017;19:627–634. doi:10.1002/ejhf.785
   PubMed Web of Science ®Google Scholar
• Yang M, Tao L, An H, et al. A novel nomogram to predict all-cause readmission or death risk in Chinese elderly patients with heart failure. ESC Heart Failure. 2020;7:1015–1024. doi:10.1002/ehf2.12703
   PubMed Web of Science ®Google Scholar
• Gao S, Yin G, Xia Q, et al. Development and validation of a nomogram to predict the 180-day readmission risk for chronic heart failure: a multicenter prospective study. Front Cardiovasc Med. 2021;8:731730. doi:10.3389/fcvm.2021.731730
   PubMed Web of Science ®Google Scholar
• Zhao E, Xie H, Zhang Y. A nomogram based on apelin-12 for the prediction of major adverse cardiovascular events after percutaneous coronary intervention among patients with ST-segment elevation myocardial infarction. Cardiovasc Ther. 2020;2020:9416803. doi:10.1155/2020/9416803
   PubMed Web of Science ®Google Scholar
• Wessler BS, Lundquist CM, Koethe B, et al. Clinical prediction models for valvular heart disease. J Am Heart Assoc. 2019;8:e011972. doi:10.1161/JAHA.119.011972
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL, et al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol. 2009;54(23):2174–2179. doi:10.1016/j.jacc.2009.07.041
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail Aug. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Lee DS, Lee JS, Schull MJ, et al. Prospective validation of the emergency heart failure mortality risk grade for acute heart failure: the acute congestive heart failure urgent care evaluation (ACUTE) study. Am Heart J. 2016;181:60–65. doi:10.1016/j.ahj.2016.07.016
   PubMed Web of Science ®Google Scholar
• Chen YJ, Sung SH, Cheng HM, et al. Performance of AHEAD score in an Asian Cohort of Acute Heart Failure with either preserved or reduced left ventricular systolic function. J Am Heart Assoc. 2017;6. doi:10.1161/JAHA.116.004297
   Web of Science ®Google Scholar
• Aimo A, Vergaro G, Ripoli A, et al. Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure. JACC Heart Fail. 2017;5(4):287–296. doi:10.1016/j.jchf.2016.12.016
   PubMed Web of Science ®Google Scholar
• Dutka M, Bobiński R, Ulman-Włodarz I, et al. Various aspects of inflammation in heart failure. Heart Fail Rev. 2020;25:537–548. doi:10.1007/s10741-019-09875-1
   PubMed Web of Science ®Google Scholar
• Wang K, Ni G, Wu Q, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide and glomerular filtration rate in patients with acute heart failure. Front Cardiovasc Med. 2020;7:123. doi:10.3389/fcvm.2020.00123
   PubMed Web of Science ®Google Scholar
• Cheang I, Liao S, Yao W, et al. Cystatin C-based CKD-EPI estimated glomerular filtration rate equations as a better strategy for mortality stratification in acute heart failure. Medicine. 2020;99(44):e22996. doi:10.1097/MD.0000000000022996
   PubMed Web of Science ®Google Scholar
• Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209–216. doi:10.1016/j.ahj.2004.08.005
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Thomas Heywood J, Heidenreich PA, et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153(6):1021–1028. doi:10.1016/j.ahj.2007.03.012
   PubMed Web of Science ®Google Scholar
• Xiao J, Gao R, Bei Y, et al. Circulating miR-30d predicts survival in patients with acute heart failure. Cell Physiol Biochem. 2017;41(3):865–874. doi:10.1159/000459899
   PubMedGoogle Scholar
• Wu X, Chen M, Wang K, et al. Gender differences in prognostic markers of all-cause death in patients with acute heart failure: a prospective 18-month follow-up study. J Cardiovasc Transl Res. 2020;13(1):97–109. doi:10.1007/s12265-019-09893-2
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine. Eur J Heart Fail. 2010;12:423–433. doi:10.1093/eurjhf/hfq045
   PubMed Web of Science ®Google Scholar
• Matsushita K, Mahmoodi BK, Woodward M; Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941–1951. doi:10.1001/jama.2012.3954
   PubMed Web of Science ®Google Scholar
• Landerman LR, Land KC, Pieper CF. An empirical evaluation of the predictive mean matching method for imputing missing values. Sociol Methods Res. 1997;26(1):3–33. doi:10.1177/0049124197026001001
   Web of Science ®Google Scholar
• Das KK, Geng X, Brown JW, et al. Cross validation of the monoclonal antibody das-1 in identification of high-risk mucinous pancreatic cystic lesions. Gastroenterology. 2019;157:720–730. doi:10.1053/j.gastro.2019.05.014
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen P, Zhou Q, et al. A novel immune-related prognostic signature in head and neck squamous cell carcinoma. Front Genet. 2021;12:570336. doi:10.3389/fgene.2021.570336
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang M, Jia J, et al. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: a retrospective analysis of two independent cohorts. EBioMedicine. 2020;60:103016. doi:10.1016/j.ebiom.2020.103016
   PubMed Web of Science ®Google Scholar
• Su. Y-S, Gelman A, Hill J. Multiple imputation with diagnostics (mi) in R: opening windows into the Black Box. J Stat Softw. 2011;45:1–31. doi:10.18637/jss.v045.i02
   Web of Science ®Google Scholar
• Harrell FE. Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, USA: Springer-Verlag New York, Inc.; 2001.
   Google Scholar
• Dauriz M, Targher G, Temporelli PL, et al. Prognostic Impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: a Post‐Hoc analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) trial. J Am Heart Assoc. 2017;6(7):e005156. doi:10.1161/JAHA.116.005156
   PubMed Web of Science ®Google Scholar
• Yang J, Tian G, Pan Z, et al. Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis. Future Oncol. 2019;15(26):3033–3045. doi:10.2217/fon-2019-0029
   PubMed Web of Science ®Google Scholar
• Thomas LE, O’Brien EC, Piccini JP, et al. Application of net reclassification index to non-nested and point-based risk prediction models: a review. Eur Heart J. 2019;40(23):1880–1887. doi:10.1093/eurheartj/ehy345
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB, D’Agostino RB. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:207–212. doi:10.1002/sim.3106
   Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804. doi:10.1016/j.eururo.2018.08.038
   PubMed Web of Science ®Google Scholar
• Jalali A, Alvarez-Iglesias A, Roshan D, et al. Visualising statistical models using dynamic nomograms. PLoS One. 2019;14(11):e0225253. doi:10.1371/journal.pone.0225253
   PubMed Web of Science ®Google Scholar
• Shah KB, Kop WJ, Christenson RH, et al. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction. Clin Chem. 2011;57(6):874–882. doi:10.1373/clinchem.2010.159277
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200. doi:10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• Januzzi JL, Mebazaa A, Di Somma S. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel. Am J Cardiol. 2015;115(7 Suppl):26B–31B. doi:10.1016/j.amjcard.2015.01.037
   PubMed Web of Science ®Google Scholar
• Shah RV, Chen-Tournoux AA, Picard MH, et al. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail. 2009;2(4):311–319. doi:10.1161/CIRCHEARTFAILURE.108.833707
   PubMed Web of Science ®Google Scholar
• Zilinski JL, Shah RV, Gaggin HK, et al. Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy. Crit Care. 2012;16(4):R135. doi:10.1186/cc11440
   PubMed Web of Science ®Google Scholar
• Lassus J, Gayat E, Mueller C, et al. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol. 2013;168(3):2186–2194. doi:10.1016/j.ijcard.2013.01.228
   PubMed Web of Science ®Google Scholar
• Januzzi JL, Peacock WF, Maisel AS, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007;50(7):607–613. doi:10.1016/j.jacc.2007.05.014
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Chronic heart failure in adults: diagnosis and management: NICE guideline [NG106] [Internet]. London: NICE; [ cited September 19, 2018] 2018. Available from: https://www.nice.org.uk/guidance/ng106. Accessed March 10, 2022.
   Google Scholar
• Booth RA, Hill SA, Don-Wauchope A, et al. Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review. Heart Fail Rev. 2014;19(4):439–451. doi:10.1007/s10741-014-9445-8
   PubMed Web of Science ®Google Scholar
• Li X, Chen C, Gan F, et al. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study. BMC Cardiovasc Disord. 2014;14:67. doi:10.1186/1471-2261-14-67
   PubMed Web of Science ®Google Scholar
• Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27(3):330–337. doi:10.1093/eurheartj/ehi631
   PubMed Web of Science ®Google Scholar
• Alventosa-Zaidin M, Guix Font L, Benitez Camps M, et al. Right bundle branch block: prevalence, incidence, and cardiovascular morbidity and mortality in the general population. Eur J Gen Pract. 2019;25(3):109–115. doi:10.1080/13814788.2019.1639667
   PubMed Web of Science ®Google Scholar
• Sabe MA, Sabe SA, Kusunose K, et al. Predictors and prognostic significance of right ventricular ejection fraction in patients with ischemic cardiomyopathy. Circulation. 2016;134:656–665. doi:10.1161/CIRCULATIONAHA.116.022339
   PubMed Web of Science ®Google Scholar
• Eriksson P, Wilhelmsen L, Rosengren A. Bundle-branch block in middle-aged men: risk of complications and death over 28 years. Eur Heart J. 2005;26(21):2300–2306. doi:10.1093/eurheartj/ehi580
   PubMed Web of Science ®Google Scholar
• Bussink BE, Holst AG, Jespersen L, et al. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Eur Heart J. 2013;34(2):138–146. doi:10.1093/eurheartj/ehs291
   PubMed Web of Science ®Google Scholar
• Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40–47. doi:10.1016/j.jacc.2007.02.067
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail. 2009;11(9):840–846. doi:10.1093/eurjhf/hfp109
   PubMed Web of Science ®Google Scholar
• Senthong V, Hudec T, Neale S, et al. Relation of red cell distribution width to left ventricular end-diastolic pressure and mortality in patients with and without heart failure. Am J Cardiol. 2017;119(9):1421–1427. doi:10.1016/j.amjcard.2017.01.036
   PubMed Web of Science ®Google Scholar
• Fonarow GC. The treatment targets in acute decompensated heart failure. Rev Cardiovasc Med. 2001;2(Suppl 2):S7–S12.
   PubMedGoogle Scholar
• Morici N, Viola G, Antolini L, et al. Predicting survival in patients with acute decompensated heart failure complicated by cardiogenic shock. Int J Cardiol Heart Vasc. 2021;34:100809. doi:10.1016/j.ijcha.2021.100809
   PubMed Web of Science ®Google Scholar
• Collins SP, Jenkins CA, Harrell FE, et al. Identification of emergency department patients with acute heart failure at low risk for 30-day adverse events: the STRATIFY decision tool. JACC Heart Fail. 2015;3(10):737–747. doi:10.1016/j.jchf.2015.05.007
   PubMed Web of Science ®Google Scholar
• Chen Y, Sung S, Cheng H, et al. Performance of AHEAD score in an Asian cohort of acute heart failure with either preserved or reduced left ventricular systolic function. J Am Heart Assoc. 2017;6(5):e004297.
   PubMed Web of Science ®Google Scholar
• Coles AH, Tisminetzky M, Yarzebski J, et al. Magnitude of and prognostic factors associated with 1‐year mortality after hospital discharge for acute decompensated heart failure based on ejection fraction findings. J Am Heart Assoc. 2015;4(12):e002303. doi:10.1161/JAHA.115.002303
   PubMed Web of Science ®Google Scholar